Benzinga | Aug 12, 2021 04:46PM EDT

4D Molecular Therapeutics Q2 EPS $(0.28) Up From $(2.92) YoY, Sales $14.58M Up From $3.63M YoY

4D Molecular Therapeutics (NASDAQ:FDMT) reported quarterly losses of $(0.28) per share. This is a 90.41 percent increase over losses of $(2.92) per share from the same period last year. The company reported $14.58 million in sales this quarter. This is a 301.32 percent increase over sales of $3.63 million the same period last year.